Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Assets (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Non-Current Assets for 12 consecutive years, with $184000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets fell 63.71% year-over-year to $184000.0, compared with a TTM value of $1.2 million through Sep 2025, down 51.12%, and an annual FY2024 reading of $424000.0, down 44.94% over the prior year.
  • Non-Current Assets was $184000.0 for Q3 2025 at Lisata Therapeutics, down from $275000.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.0 million in Q1 2023 and bottomed at $184000.0 in Q3 2025.
  • Average Non-Current Assets over 3 years is $602181.8, with a median of $593000.0 recorded in 2024.
  • The sharpest move saw Non-Current Assets plummeted 33.75% in 2024, then crashed 63.71% in 2025.
  • Year by year, Non-Current Assets stood at $770000.0 in 2023, then crashed by 44.94% to $424000.0 in 2024, then tumbled by 56.6% to $184000.0 in 2025.
  • Business Quant data shows Non-Current Assets for LSTA at $184000.0 in Q3 2025, $275000.0 in Q2 2025, and $364000.0 in Q1 2025.